Larson Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$357K Sell
636
-94
-13% -$60.3K 0.01% 575
2025
Q4
$494K Buy
730
+381
+109% +$259K 0.02% 466
2025
Q3
$223K Sell
349
-502
-59% -$305K 0.01% 662
2025
Q2
$456K Buy
851
+181
+27% +$86.6K 0.02% 461
2025
Q1
$281K Buy
670
+61
+10% +$26.5K 0.01% 548
2024
Q4
$252K Sell
609
-1,645
-73% -$722K 0.01% 514
2024
Q3
$1.14M Buy
2,254
+2,241
+17,238% +$1.09M 0.06% 213
2024
Q2
$6.33K Buy
13
+6
+86% +$3.01K ﹤0.01% 1386
2024
Q1
$3.78K Sell
7
-10
-59% -$5.46K ﹤0.01% 1249
2023
Q4
$9.44K Sell
17
-17
-50% -$7.98K ﹤0.01% 1032
2023
Q3
$14.9K Buy
34
+18
+113% +$8.98K ﹤0.01% 893
2023
Q2
$8.04K Buy
16
+6
+60% +$2.88K ﹤0.01% 995
2023
Q1
$5K Hold
10
﹤0.01% 1086
2022
Q4
$4.08K Hold
10
﹤0.01% 1072
2022
Q3
$3K Hold
10
﹤0.01% 1052
2022
Q2
$4K Buy
+10
New +$4.08K ﹤0.01% 905
2022
Q1
Sell
-124
Closed -$82K 1104
2021
Q4
$82K Buy
+124
New +$77.8K 0.01% 305

Other funds holding IDXX

Larson Financial Group's IDXX Position: Q1 2026 in Review

Larson Financial Group reduced its Idexx Laboratories (IDXX) stake by 13% in Q1 2026, selling an estimated $60.3K and leaving 636 shares worth $357K. The position accounts for 0.01% of the portfolio, ranked #575.

Larson Financial Group first reported a position in IDXX in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.14M in Q3 2024. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Larson Financial Group held 636 shares of Idexx Laboratories worth $357K as of Q1 2026.
  • Larson Financial Group sold 94 Idexx Laboratories shares in Q1 2026, an estimated $60.3K.
  • Idexx Laboratories made up 0.01% of Larson Financial Group's portfolio in Q1 2026, its #575 holding.
  • Larson Financial Group first reported a position in Idexx Laboratories in Q4 2021 and has held it in 17 quarters since.
  • Larson Financial Group's Idexx Laboratories position peaked at $1.14M in Q3 2024.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.